247 related articles for article (PubMed ID: 20526717)
1. Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
Chen KH; Hsu CC; Song WS; Huang CS; Tsai CC; Kuo CD; Hsu HS; Tsai TH; Tsai CY; Woung LC; Chiou SH; Lu KH; Chen YW
Childs Nerv Syst; 2010 Nov; 26(11):1605-12. PubMed ID: 20526717
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.
Yang MY; Lee HT; Chen CM; Shen CC; Ma HI
Int J Mol Sci; 2014 Jun; 15(6):11013-29. PubMed ID: 24945311
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells.
Chang CJ; Chiang CH; Song WS; Tsai SK; Woung LC; Chang CH; Jeng SY; Tsai CY; Hsu CC; Lee HF; Huang CS; Yung MC; Liu JH; Lu KH
Childs Nerv Syst; 2012 Mar; 28(3):363-73. PubMed ID: 22249380
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor.
Kao CL; Huang PI; Tsai PH; Tsai ML; Lo JF; Lee YY; Chen YJ; Chen YW; Chiou SH
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):219-28. PubMed ID: 19362240
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells.
Deng Y; Su Q; Mo J; Fu X; Zhang Y; Lin EH
Cancer Invest; 2013 Feb; 31(2):97-102. PubMed ID: 23245395
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.
Klenke FM; Abdollahi A; Bischof M; Gebhard MM; Ewerbeck V; Huber PE; Sckell A
Strahlenther Onkol; 2011 Jan; 187(1):45-51. PubMed ID: 21234531
[TBL] [Abstract][Full Text] [Related]
9. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity.
Yu CC; Chiou GY; Lee YY; Chang YL; Huang PI; Cheng YW; Tai LK; Ku HH; Chiou SH; Wong TT
Childs Nerv Syst; 2010 Jul; 26(7):897-904. PubMed ID: 20179950
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
13. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
14. The Antiproliferative and Pro-apoptotic Effects of Methoxyamine on Pediatric Medulloblastoma Cell Lines Exposed to Ionizing Radiation and Chemotherapy.
Pezuk JA; Valera ET; Delsin LE; Scrideli CA; Tone LG; Brassesco MS
Cent Nerv Syst Agents Med Chem; 2015; 16(1):67-72. PubMed ID: 26553097
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib enhances the radiosensitizing effect of 7-hydroxystaurosporine (UCN-01) in human lung cancer cell lines.
Kim YM; Jeong IH; Pyo H
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e399-407. PubMed ID: 22417802
[TBL] [Abstract][Full Text] [Related]
16. COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells.
Kim SJ; Ha GH; Bae JH; Kim GR; Son CH; Park YS; Yang K; Oh SO; Kim SH; Kang CD
Exp Cell Res; 2015 Jan; 330(2):451-459. PubMed ID: 25218028
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma.
Zhang SX; Qiu QH; Chen WB; Liang CH; Huang B
Cell Physiol Biochem; 2014; 33(5):1484-97. PubMed ID: 24854838
[TBL] [Abstract][Full Text] [Related]
18. A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma.
Yusup G; Akutsu Y; Mutallip M; Qin W; Hu X; Komatsu-Akimoto A; Hoshino I; Hanari N; Mori M; Akanuma N; Isozaki Y; Matsubara H
Int J Oncol; 2014 Apr; 44(4):1146-52. PubMed ID: 24535229
[TBL] [Abstract][Full Text] [Related]
19. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.
Chen YC; Hsu HS; Chen YW; Tsai TH; How CK; Wang CY; Hung SC; Chang YL; Tsai ML; Lee YY; Ku HH; Chiou SH
PLoS One; 2008 Jul; 3(7):e2637. PubMed ID: 18612434
[TBL] [Abstract][Full Text] [Related]
20. Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.
Shu Q; Wong KK; Su JM; Adesina AM; Yu LT; Tsang YT; Antalffy BC; Baxter P; Perlaky L; Yang J; Dauser RC; Chintagumpala M; Blaney SM; Lau CC; Li XN
Stem Cells; 2008 Jun; 26(6):1414-24. PubMed ID: 18403755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]